Jeannie Swafford
Medical · Goodlettsville, TNNPI 1811220130
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 421 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Novo Nordisk at 25.5% of the total. Reporting peaked in 2023 at $1,766 and has fallen 58.1% since, to $741 in 2025. Among medical clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AbbVie$948
- Lilly USA, LLC$614
- Pfizer$506
- Mannkind Corporation$447
- Xeris Pharmaceuticals, Inc.$403
- plus $2K from 24 others
What the payments were for
- Food & beverage$7,132100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 101 | $1,821 |
| AbbVie | 75 | $948 |
| Lilly USA, LLC | 42 | $614 |
| Pfizer | 28 | $506 |
| Mannkind Corporation | 33 | $447 |
| Xeris Pharmaceuticals, Inc. | 18 | $403 |
| Amgen | 19 | $398 |
| Sanofi-aventis U.S. LLC | 18 | $294 |
| AstraZeneca | 16 | $250 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $216 |
| Biohaven Pharmaceuticals, Inc. | 6 | $129 |
| Shield Therapeutics Inc | 6 | $123 |
| Esperion Therapeutics, Inc. | 6 | $122 |
| Boehringer Ingelheim | 6 | $120 |
| Exact Sciences | 7 | $114 |
| Merck | 5 | $81 |
| Astellas Pharma US Inc | 3 | $73 |
| Stryker | 1 | $68 |
| Novartis | 3 | $60 |
| Insulet Corporation | 3 | $56 |
| Zealand Pharma US, Inc. | 2 | $51 |
| Idorsia Pharmaceuticals US Inc | 3 | $43 |
| Hologic Sales And Service, LLC | 1 | $37 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| BETA Bionics, Inc. | 1 | $29 |
| Globus Medical | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 2 | $18 |
How this compares
$7,133 in reported general payments places this provider in the 90th percentile of 480 medical providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $43,267 |
| JardianceEmpagliflozin | 32 | $30,747 |
| MounjaroTirzepatide | 19 | $23,419 |
| FarxigaDapagliflozin Propanediol | 23 | $17,716 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $6,536 |
| Atorvastatin Calcium | 201 | $2,782 |
| Losartan Potassium | 152 | $1,740 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $1,672 |
| Levothyroxine Sodium | 188 | $1,575 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,439 |
| Metoprolol Succinate | 70 | $1,240 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 30 | $1,164 |
| Rosuvastatin Calcium | 75 | $1,090 |
| Bupropion XlBupropion Hcl | 32 | $1,070 |
| SynthroidLevothyroxine Sodium | 34 | $1,064 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,821 | $43,26737 claims |
| Boehringer IngelheimJardiance | $120 | $30,74732 claims |
| Lilly USA, LLCMounjaro | $614 | $23,41919 claims |
| AstraZenecaFarxiga | $250 | $17,71623 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $294 | $6,53611 claims |
| AbbVieSynthroid | $948 | $1,06434 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 480 medical providers in Tennessee.
Other medical in Goodlettsville
- Melissa CarterGoodlettsville$9K
- Maria WoodChattanooga$130K
- Alyssa JamesonFranklin$65K
- Melissa LambertHendersonville$47K
- Stephanie HowardKnoxville$18K
- Evan HatfillNashville$18K
- Meredith McDanielChattanooga$17K
- Janet BreedingKnoxville$15K
- Paul MabenKnoxville$13K
- Hannah KirkGreeneville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.